2023-01-02Josh Gottheimer’s purchase of ChemoCentryx ( $CCXI ) on April 19thChemoCentryx would later be acquired by Amgen, netting Gottheimer a return of over 140% on his trade.Back To Buzz
ChemoCentryx would later be acquired by Amgen, netting Gottheimer a return of over 140% on his trade.